Search clinical trials for: Secondary hyperparathyroidism,

Total 3425 results

Min-Sheng General Hospital
Taipei Medical University; Taipei Medical University Shuang Ho Hospital; National... and other collaborators

Completed

Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment

Hyperparathyroidism; Secondary, Renal

Taiwan
The Second Hospital of Nanjing Medical University

Recruiting

Total Parathyroidectomy With Autotransplantation Versus Total Parathyroidectomy Alone for Secondary Hyperparathyroidism

Secondary Hyperparathyroidism;Parathyroidectomy

China
Kyowa Kirin Co., Ltd.

Completed

Phase 1/2 Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Hemodialysis

Hyperparathyroidism

Japan
Centre Hospitalier Universitaire de Saint Etienne
University Hospital, Geneva

Completed

Association Between Serum Periostin Levels and Cortical Porosity in Patients With Secondary Hyperparathyroidism

Hyperparathyroidism

France
Phramongkutklao College of Medicine and Hospital

Completed

Effectiveness of Oral Alfacalcidol for Secondary Hyperparathyroidism in Chronic Hemodialysis Patients.

Alfacalcidol, Secondary Hyperparathyroidism, Hemodialysis
Amgen

Completed

Post Transplant Study

Hyperparathyroidism | Secondary Hyperparathyroidism | Kidney Tansplant
Genzyme, a Sanofi Company

Completed

A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis

Secondary Hyperparathyroidism

United States
Chang Gung Memorial Hospital

Completed

Pulmonary Function, Voice and Swallowing Symptoms After Parathyroidectomy

Secondary Hyperparathyroidism Due to Renal Causes

Taiwan
Fundación Senefro
AbbVie; Effice Servicios Para la Investigacion S.L.

Completed

Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation. (PARIDOINAL)

Secondary Hyperparathyroidism Due to Renal Causes

Spain
Hospices Civils de Lyon

Not yet recruiting

Study on the Use of Cinacalcet in Phosphocalcic Context. (CALCI-CINA)

Hyperparathyroidism, Primary | Hyperparathyroidism, Secondary

France
Postgraduate Institute of Medical Education and...

Unknown

Regulation of Vitamin D Receptor (VDR),Calcium Sensing Receptor (CaSR), Cyclin D1,Ki67 and Proliferating Cell Nuclear Antigen (PCNA) in Primary Hyperparathyroidism

Primary Hyperparathyroidism (PHPT)

India
National Center for Research Resources (NCRR)

Completed

Acute Regulation of Parathyroid Hormone by Dietary Phosphate

Secondary Hyperparathyroidism

United States
OPKO Health, Inc.

Completed

Pharmacokinetics and Safety Study of CTAP101 Capsules in Japanese and Non-Japanese Healthy Subjects and Non-Japanese Healthy Subjects

Secondary Hyperparathyroidism | Vitamin D Insufficiency

United States
Nantes University Hospital

Completed

Evaluation of the Interest of the Medical Device Called "Fluobeam" in the Localization, Visualization of the Parathyroid Glands for Patients With Mild Primary Hyperparathyroidism (FLUO-PARA)

Mild Primary Hyperparathyroidism

France
Shanghai Zhongshan Hospital

Unknown

Preemptive and Precise Intervention for CKD-SHPT

Hyperparathyroidism; Secondary, Renal
Azienda USL Modena

Completed

Serum Calcium to Phosphorous Ratio (Ca/P) as a Simple, Inexpensive Screening Tool in the Diagnosis of Primary Hyperparathyroidism

Hyperparathyroidism

Italy
Kerstyn C. Zalesin, M.D.
Abbott

Completed

Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secondary Hyperparathyroidism in Patients After ROUX-EN-Y Gastric Bypass Surgery (ExtenD)

Gastric Bypass | Parathyroid Hormone

United States
The Second Hospital of Anhui Medical University

Unknown

Comparison of Total Parathyroidectomy With and Without Autotransplantation

Secondary Hyperparathyroidism

China
Rambam Health Care Campus

Withdrawn

Surgical Approach for Primary Hyperparathyroidism in the Elderly

Multigland Disease in Primary Hyperparathyroidism

Israel
Shanghai Hengrui Pharmaceutical Co., Ltd.

Active, not recruiting

A Study of SHR6508 in Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

China
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

Phase 3 Study of SK-1403

Secondary Hyperparathyroidism

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

SK-1403 Long-term Treatment Study; Long-term Study in Patients With Secondary Hyperparathyroidism Receiving Hemodialysis

Secondary Hyperparathyroidism

Japan
Deltanoid Pharmaceuticals

Completed

A Phase 2A Dose-ranging and Pharmacokinetic Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

United States
Kyowa Kirin Co., Ltd.

Completed

Phase 3 Study of KHK7580

Secondary Hyperparathyroidism

Japan
KAI Pharmaceuticals

Completed

Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

United States
Penang Hospital, Malaysia
Ministry of Health, Malaysia

Unknown

Cinacalcet in Management of Secondary Hyperparathyroidism in Haemodialysis Patients

Secondary Hyperparathyroidism

Malaysia
Seoul National University Hospital
Jeil-Kirin Pharmaceutical Inc.

Completed

Cinacalcet stUdy for Peritoneal Dialysis Patients In Double Arm on the Lowing Effect OF iPTH Level (CUPID)

Secondary Hyperparathyroidism

Korea, Republic of
Nantes University Hospital
Institut National de la Santé Et de la Recherche Médicale, France

Recruiting

Cohort Primary Hyperparathyroidism (CoHPT)

Primary Hyperparathyroidism

France
Brigham and Women's Hospital

Completed

Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism

Primary Hyperparathyroidism

United States
University Hospital Inselspital, Berne

Completed

The Crosstalk Between Calcium-sensing Receptor Signaling and Endocannabinoid System in Primary Hyperparathyroidism (Targeting CaSR)

Primary Hyperparathyroidism

Switzerland
EFSTATHIOS CHRONOPOULOS

Completed

Effect of Mechanical Loading on vBMD and Geometry in Patients With Primary Hyperparathyroidism

Primary Hyperparathyroidism
M.D. Anderson Cancer Center

Unknown

Percent Change in Baseline Bone Mineral Density (BMD) After Parathyroidectomy in Patients With Primary Hyperparathyroidism

Primary Hyperparathyroidism

United States
Assistance Publique - Hôpitaux de Paris

Unknown

Feasibility of Parathyroidectomy With Exploration of 4 Parathyroid Glands in Outpatients (PARAMBU)

Primary Hyperparathyroidism
CHU de Reims

Unknown

Comparison of Cervical Ultrasound and Echoscintigraphy for Preoperative Localization Diagnosis in Primary Hyperparathyroidism (ECHOPARAT)

Primary Hyperparathyroidism

France
University of Pennsylvania

Completed

EC17 for Intraoperative Imaging for Parathyroidectomy

Primary Hyperparathyroidism

United States
University of Louisville
Norton Healthcare; Jewish Hospital and St. Mary's Healthcare

Completed

Minimally Invasive Radioguided Parathyroidectomy (MIRP)

Primary Hyperparathyroidism

United States
HaEmek Medical Center, Israel
University of Zurich; University of Palermo

Terminated

Lipids Profile in Primary Hyperparathyroidism (LPHP)

Primary Hyperparathyroidism

Israel
University of British Columbia
British Columbia Cancer Agency

Unknown

11C Methionine PET for the Detection of Hyperfunctional Parathyroid Tissues

Primary Hyperparathyroidism

Canada
Columbia University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Primary Hyperparathyroidism: Non-classical Manifestations

Primary Hyperparathyroidism

United States
HaEmek Medical Center, Israel

Completed

Effects of Parathyroidectomy on Cardiovascular Risk Factors in Primary Hyperparathyroidism

Primary Hyperparathyroidism

Israel
Abbott
Statistika Consultoria Ltda

Terminated

Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects

Secondary Hyperparathyroidism | Dialysis

Brazil
China-Japan Friendship Hospital

Recruiting

Single-Cell Sequence Technology Used to Reveal Heterogeneity of Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

China
Kyowa Kirin Co., Ltd.
Kyowa Hakko Kirin China Pharmaceutical Co., LTD.; Kyowa Kirin Korea Co., Ltd.

Completed

Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in Asia

Secondary Hyperparathyroidism

China, Hong Kong, Korea, Republic of, Taiwan
Hospital General Ajusco Medio

Completed

IOPTH Usefulness for Predicting Successful Surgery in Secondary Hyperparathyroidism

Secondary Hyperparathyroidism

Mexico
Kyowa Kirin Co., Ltd.

Completed

Phase 3 Study of KHK7580

Secondary Hyperparathyroidism

Japan
Kumamoto University

Completed

Maintenance Vitamin D Therapy for Secondary Hyperparathyroidism (2HPT)

Secondary Hyperparathyroidism

Japan
Kyowa Kirin Co., Ltd.

Completed

Study of KHK7580 for Secondary Hyperparathyroidism in Patients Receiving Peritoneal Dialysis

Secondary Hyperparathyroidism

Japan
Mersin University

Completed

Changes in Cardiac Functions in Patients Treated With Parathyroidectomy for Secondary Hyperparathyroidism

Secondary Hyperparathyroidism | Myocardial Dysfunction

Turkey
Amgen

Completed

A Phase 1 Study to Evaluate PK, Safety and Tolerability of AMG 416

Secondary Hyperparathyroidism

China
Wenhu Liu

Unknown

The Efficacy and Safety of Microwave Ablation for Mild-to-moderate Secondary Hyperparathyroidism Patients Undergoing Hemodialysis

Secondary Hyperparathyroidism | Maintenance Hemodialysis

China

Search clinical trials for: Secondary hyperparathyroidism,

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Montenegro

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations